In summary, PSP demonstrates promising potential as a natural multi-target therapeutic agent for diabetes, primarily by enhancing mitochondrial function and reducing β-cell apoptosis via activation of the AMPK-SIRT1 axis. Here, SIRT1 is linked to diabetes mellitus.